Star Pharma
Edit Page
Report
Scan day: 02 February 2014 UTC
20
Virus safety - good
Description: Develops dendrimer nanotechnology products for pharmaceutical, life-science and other applications.
Appendix 4C - Quarterly Cashflow Report Starpharma commences Dendrimer-Docetaxel clinical trial Starpharma to recoup additional $2 million for overseas R&D Cancer Australia funding for dendrimer-based lung treatment
Size: 223 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
Page title: | Starpharma |
Keywords: | Starpharma Holdings Limited, dendrimer, Starpharma, VivaGel®, SPL7013, vaginal microbicide, sexually transmitted infections (STI), HIV, genital herpes, bacterial Vaginosis (BV), condom coating, Durex® condoms, sexual health, pharmaceutical, dendrimer drug delivery, drug targeting, drug solubilisation, diagnostics, pharmaceutical excipients, dendrimer, materials science, cosmetics, agrochemicals. |
Description: | |
IP-address: | 27.131.71.131 |
WHOIS Info
NS | Name Server: NS61.WORLDNIC.COM Name Server: NS62.WORLDNIC.COM |
WHOIS | Status: clientTransferProhibited |
Date | Creation Date: 31-mar-1999 Expiration Date: 31-mar-2015 |